Sign in
4

Changes in Ownership

HCW Biologics Inc. Filed Acc 0001209191-21-055525

Options or other derivatives

  • Chief Executive Officer acquired 800,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Wong Hing C · Chief Executive Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-09-08 Grant or award : show line 1 in the form Stock Option (Right to Buy) +800,000 800,000 D
Loading xslF345X03/doc4.xml…